Invesco Ltd. 13D and 13G filings for Phathom Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 11:45 am Purchase |
2024-02-07 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Invesco Ltd. IVZ |
3,167,653 5.500% |
960,004 (+43.49%) |
Filing |
| 2023-02-02 3:08 pm Purchase |
2023-02-02 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Invesco Ltd. IVZ |
2,207,649 5.300% |
140,293 (+6.79%) |
Filing |
| 2022-02-10 11:32 am Purchase |
2022-02-09 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Invesco Ltd. IVZ |
2,067,356 6.600% |
12,918 (+0.63%) |
Filing |
| 2021-02-12 2:53 pm Sale |
2021-02-12 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Invesco Ltd. IVZ |
2,054,438 6.600% |
-47,865 (-2.28%) |
Filing |